List of Excipients in API NEFAZODONE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing NEFAZODONE HYDROCHLORIDE
Detailed excipient profiles for NEFAZODONE HYDROCHLORIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
NEFAZODONE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
NEFAZODONE HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
NEFAZODONE HYDROCHLORIDE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | nefazodone hydrochloride | 16590-166 |
| >Company | >Ingredient | >NDC |
NEFAZODONE HYDROCHLORIDE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: FERRIC OXIDE RED
NEFAZODONE HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | nefazodone hydrochloride | 0093-7178 |
| Bryant Ranch Prepack | nefazodone hydrochloride | 63629-7046 |
| Preferred Pharmaceuticals Inc | nefazodone hydrochloride | 68788-7246 |
| >Company | >Ingredient | >NDC |
NEFAZODONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | nefazodone hydrochloride | 16590-166 |
| Rebel Distributors Corp | nefazodone hydrochloride | 21695-176 |
| Preferred Pharmaceuticals Inc | nefazodone hydrochloride | 68788-7217 |
| Preferred Pharmaceuticals Inc | nefazodone hydrochloride | 68788-7242 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
NEFAZODONE HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | nefazodone hydrochloride | 21695-176 |
| Bryant Ranch Prepack | nefazodone hydrochloride | 63629-7046 |
| Preferred Pharmaceuticals Inc | nefazodone hydrochloride | 68788-7217 |
| Preferred Pharmaceuticals Inc | nefazodone hydrochloride | 68788-7246 |
| >Company | >Ingredient | >NDC |
NEFAZODONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | nefazodone hydrochloride | 0093-7178 |
| STAT RX USA LLC | nefazodone hydrochloride | 16590-166 |
| Preferred Pharmaceuticals Inc | nefazodone hydrochloride | 68788-7242 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
NEFAZODONE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
NEFAZODONE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
NEFAZODONE HYDROCHLORIDE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | nefazodone hydrochloride | 16590-166 |
| Rebel Distributors Corp | nefazodone hydrochloride | 21695-176 |
| >Company | >Ingredient | >NDC |
NEFAZODONE HYDROCHLORIDE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
NEFAZODONE HYDROCHLORIDE drug variants containing POVIDONE K30
NEFAZODONE HYDROCHLORIDE drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | nefazodone hydrochloride | 16590-166 |
| Rebel Distributors Corp | nefazodone hydrochloride | 21695-176 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
NEFAZODONE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
NEFAZODONE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | nefazodone hydrochloride | 16590-166 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
NEFAZODONE HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
NEFAZODONE HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
